News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Temozolomide Trial Shows Improved 5-Year Survival Rates in Anaplastic Glioma

Al's Comment:

 We already knew this - but strangely I hear of many patients who do not get Temozolomide at the same time as radiation for Anaplastic Astrocytomas. This article should hopefully change that.  


Posted on: 06/04/2016

Temozolomide Trial Shows Improved 5-Year Survival Rates in Anaplastic Glioma - See more at: http://www.onclive.com/conference-coverage/asco-2016/temozolomide-trial-shows-improved-5year-survival-rates-in-anaplastic-glioma#sthash.ukoMtPWX.dpuf

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc